Portfolio company
iiDiagnostics
United Kingdom
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This Liverpool School of Tropical Medicine subsidiary develops sensors and diagnostic tools for infectious disease control, specifically targeting malaria prevention for international health organisations.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Limosa Immunodiagnostics
This company develops diagnostic tests for latent tuberculosis and other immune-related diseases for patients and healthcare providers.
FluoretiQ Limited
This company develops rapid point-of-care diagnostic tests that identify bacterial infections and antibiotic sensitivity for clinicians and veterinarians.
Transdermal Diagnostics
This company develops needle-free, continuous glucose monitoring patches for people living with diabetes and prediabetes to manage blood sugar levels non-invasively.
Abacus Diagnostica
This company develops molecular diagnostic systems for infectious disease testing, serving hospital laboratories and healthcare units.
HiberGene
HiberGene Diagnostics manufactures molecular diagnostic tests for infectious diseases for sale to healthcare providers and institutions via a global network of independent distributors.
Pictura Bio
This company develops point-of-care diagnostic tools using machine learning and microscopy to identify pathogens in respiratory samples for clinicians and healthcare providers.
Novus Diagnostic
Novus Diagnostics develops point-of-care diagnostic devices for clinicians to detect and classify bloodstream infections, specifically sepsis, within fifteen minutes at the bedside.
DxLab
This company develops point-of-care molecular testing systems and rapid diagnostic tests for pathogens to serve healthcare providers and public health teams.
